Antiarrhythmic Medications for Atrial Fibrillation (AFib)
Rhythm-control medicines, called antiarrhythmics, help your heart maintain a normal rhythm and reduce AFib episodes. Because every heart is different, the best option depends on several factors. Your doctor will consider your symptoms, heart structure and function, kidney health, and other medical conditions to choose a medication that is safe and effective for you.
Make An Appointment
Call 216-844-3800 to schedule an appointment with a UH atrial fibrillation specialist today.
The content of this page was reviewed by Esseim Sharma, MD,
Cardiac Electrophysiologist, University Hospitals Harrington Heart & Vascular Institute, on March 2026.
Quick Facts
- Rhythm-control medicines help your heart stay in a normal, steady beat instead of fluttering or racing.
- These drugs are different from medicines that simply slow down a fast heart rate or blood thinners that protect you from strokes.
- While these medicines can reduce your symptoms and AFib episodes, they are not a permanent cure and do not replace the need for blood thinners.
- The specific medicine your doctor chooses depends on your unique heart structure, your kidney health, and other medical conditions.
- Certain rhythm-control medicines must be started in the hospital so your medical team can safely monitor your heart’s electrical signals during the first few doses.
- Antiarrhythmic medications are rhythm‑control drugs that help the heart stay in a more regular rhythm.
- They are different from rate‑control drugs (which slow the heart rate) and blood thinners (which lower stroke risk).
- They can reduce AFib episodes and symptoms but do not cure AFib or replace blood thinners when stroke risk is high.
- The right medication depends on symptoms, heart structure, other heart disease, kidney function and other conditions.
What Are Antiarrhythmic Medications for AFib?
Antiarrhythmic medications are drugs that change how electrical signals move through the heart to maintain a more regular and organized rhythm. By restoring electrical order, they reduce the frequency and severity of AFib episodes and improve symptoms like palpitations, fatigue and shortness of breath.
Antiarrhythmic drugs are one part of a comprehensive AFib treatment plan. While antiarrhythmic medications can significantly reduce AFib episodes and improve symptoms, they do not cure AFib and do not replace blood thinners when your stroke risk is high.
It’s important to note that antiarrhythmics do not cure AFib, do not restore permanent normal rhythm in all patients and do not replace blood thinners for stroke prevention. They may be used alone in early-stage AFib, combined with other medications or as a “bridge” treatment while considering other options like ablation. It’s helpful to understand how different AFib medications work together:
- Rhythm-control drugs (antiarrhythmics) work to restore and maintain normal heart rhythm.
- Rate-control drugs (beta-blockers, calcium channel blockers) slow a fast heart rate but don’t treat the irregular rhythm itself.
- Anticoagulants (blood thinners) don’t treat AFib directly, but prevent stroke by reducing blood clot risk.
Your care team may recommend rhythm control, rate control or a combination of medications depending on your symptoms, AFib type and overall health.
Who May Be a Candidate for Antiarrhythmic Medication?
Antiarrhythmic medications are appropriate for many AFib patients, but whether you are a candidate depends on your individual situation. Your cardiologist or electrophysiologist will evaluate whether rhythm-control therapy is right for you based on several factors.
You may be a candidate if you:
- Have symptomatic paroxysmal AFib (episodes that come and go) or persistent AFib (continuous rhythm problem) causing bothersome symptoms.
- Continue to have AFib symptoms despite rate-control medications.
- Are planning to undergo cardioversion (electrical shock to restore normal rhythm) and need medication to prevent AFib recurrence.
- Are considering ablation, and want to try medication first.
- Had a previous unsuccessful ablation and need additional rhythm control.
You may not be a candidate if you:
- Have significant heart failure, structural heart disease or severely weakened heart function, which can make certain antiarrhythmic drugs dangerous.
- Have severe kidney disease.
- Are unable comply with required monitoring or follow-up care.
Not sure if you’re a candidate?
Your UH cardiologist or electrophysiologist can evaluate your AFib type, heart anatomy, overall health and treatment history to determine if an antiarrhythmic medication is right for you. Schedule a consultation to discuss your options.
What Are the Main Types of Antiarrhythmic Drugs?
Antiarrhythmic medications are organized into different classes based on how they work. Here are the main types used to treat AFib:
Class Ic Medications: Flecainide and Propafenone
These drugs work by slowing electrical conduction in the heart to prevent irregular rhythms. They’re effective for reducing AFib episodes in patients without structural heart disease. Class Ic medications are typically taken twice daily as oral tablets. Patients need baseline heart testing (EKG, echocardiogram, and stress test) before starting, and regular follow-up care to monitor the treatment’s effectiveness and side effects.
Class III Medications: Sotalol, Dofetilide (Tikosyn) and Amiodarone
These drugs work by blocking potassium channels and slowing electrical activity in the heart. They’re used for various AFib types and can be very effective, but each one has specific considerations:
- Sotalol is a beta-blocker that slows heart rate and helps maintain rhythm. It requires kidney function monitoring and baseline EKG.
- Dofetilide (Tikosyn) is a potent rhythm-control drug often used for persistent AFib. Because of the risk of a dangerous heart rhythm called torsades de pointes, dofetilide must be started in the hospital with continuous monitoring for at least three days when it’s first initiated. Kidney function and QT interval (electrical measurement on EKG) must be closely watched.
- Amiodarone is a powerful antiarrhythmic effective for many AFib patients, but it can cause serious side effects with long-term use, including thyroid, liver and lung problems. Amiodarone requires frequent blood tests, thyroid monitoring and regular chest X-rays. It’s typically reserved for patients who have heart or kidney failure or haven’t responded to other medications.
What this means for patients
Different antiarrhythmic drugs work in different ways and suit different patients. Your cardiologist will choose the medication — or combination of medications — that balances effectiveness with safety based on your heart structure, kidney function, other medical conditions and ability to tolerate monitoring. Some medications can be started as outpatient therapy, while others (like dofetilide) require hospitalization for safety monitoring. Regular follow-up, blood work and heart testing are essential to ensure your medication is working and not causing harm.
What Are the Risks and Side Effects of Antiarrhythmic Medications?
Like all medications, antiarrhythmics can cause side effects. Common ones include fatigue, dizziness, nausea and headache. Most side effects are mild and improve over time, but some patients need to switch medications if side effects are bothersome or intolerable.
More serious risks depend on the specific drug. Flecainide and propafenone can sometimes trigger dangerous heart rhythms (proarrhythmia), particularly in patients with structural heart disease. That is why baseline heart testing is essential before starting. While very effective, amiodarone can damage the thyroid, liver and lungs with long-term use. Sotalol and dofetilide can cause QT prolongation, an electrical change on the heart that increases the risk of dangerous rhythms.
To help minimize and manage the risks of antiarrhythmic medications, it is essential that you follow your care plan for regular monitoring with blood work, EKGs and follow-up appointments. Your care team will watch for signs of toxicity or dangerous rhythms and adjust your medication if needed. If you experience chest pain, severe dizziness, fainting, shortness of breath, or rapid or very slow heart rate while on an antiarrhythmic, contact your doctor immediately.
How Are Antiarrhythmic Medications Monitored?
- Starting a new antiarrhythmic
-
Some medications can be started safely at home after baseline testing (EKG, echocardiogram, blood work). Others – especially dofetilide (Tikosyn) – must be started while you’re in the hospital, where your heart rhythm can be continuously monitored for at least three days. Hospital initiation allows doctors to watch for dangerous rhythm changes and adjust dosing safely before you go home.
- Ongoing monitoring
-
Once you’re on an antiarrhythmic, you’ll have regular follow-up appointments and periodic testing to ensure the medication is working and not causing harm. This typically includes:
- EKGs to check heart rhythm and QT interval (especially important for Class III drugs like sotalol and dofetilide).
- Blood work to monitor kidney function, liver function and drug levels.
- Occasional echocardiograms to assess heart structure.
- Symptom tracking to evaluate whether AFib episodes are decreasing.
- What symptoms to report immediately
-
Contact your care team right away if you experience chest pain, fainting, severe dizziness, shortness of breath, rapid or very slow heart rate, new palpitations or unusual fatigue while on medication.
When Should Patients Transition From Medications to Procedures?
Antiarrhythmic medications work well for many AFib patients, but most people will still benefit from procedures such as ablation or cardioversion. Your electrophysiologist will help you decide when to consider a procedure.
Reasons to consider transitioning to a procedure include:
Medication isn’t controlling symptoms.
If AFib episodes persist despite trying one or more antiarrhythmic drugs, ablation may offer better long-term rhythm control.
Side effects are limiting quality of life.
If medication side effects are intolerable or dangerous, a procedure may be a better option than ongoing drug therapy.
AFib recurs after a cardioversion procedure.
If you’ve had electrical cardioversion but AFib returns despite medication, ablation could offer a better success rate than medication alone.
You prefer a definitive approach.
Some people prefer the permanence of ablation over lifelong medication, and may opt for an ablation rather than trying a medicine.
Ablation is recommended as first-line treatment.
Ablation is increasingly recommended by care guidelines as first-line therapy for many patients with atrial fibrillation.
Why Choose University Hospitals for AFib Medication Management?
Our AFib program provides comprehensive medication management within an integrated care ecosystem that spans medications, cardioversion, ablation, surgical options and device therapy.
Cardiologists and electrophysiologists at UH Harrington Heart & Vascular Institute carefully match antiarrhythmic medications to each patient’s heart structure, condition, lifestyle and overall health. We help patients understand why a specific drug is right for their situation, and adjust therapy if needed based on effectiveness and side effects.
For patients on AFib medication, we offer comprehensive follow-up care. Our integrated AFib program ensures consistent, coordinated monitoring with regular EKGs, blood work and clinical assessments. Our team tracks your response to medication and watches for side effects or toxicity. If inpatient drug initiation is needed, our inpatient facilities support safe, monitored drug initiation with continuous heart rhythm and QT interval monitoring, allowing patients to start therapy safely and return home with confidence.
We believe medication choices should be collaborative. Your UH care team will discuss the evidence, risks, benefits and alternatives so you can make an informed decision about your AFib treatment. If medication isn’t working or becomes intolerable, our team seamlessly transitions patients to cardioversion, catheter ablation, surgical ablation or other options. Our cardiologists and electrophysiologists coordinate your care across the full AFib treatment spectrum.
Frequently Asked Questions about Antiarrhythmic Drug Therapy
- Is antiarrhythmic medication covered by insurance?
-
Most commercial insurance plans and Medicare cover antiarrhythmic medications when prescribed for AFib, though some may require prior authorization by your insurance company. UH’s billing and insurance team can help verify coverage and navigate any authorization requirements before you start medication.
- How long does it take for antiarrhythmic medications to work?
-
Many antiarrhythmic medications begin reducing AFib episodes within days, but full stabilization typically takes several weeks as your doctor adjusts your dose and monitors how your heart responds. Be patient — your rhythm may improve gradually, and your care team will evaluate how well they are working at follow-up appointments, and adjust if needed.
- What are the risks or side effects?
-
Common side effects include fatigue, dizziness and nausea, which often improve over time. Drug-specific risks vary: flecainide and propafenone have a risk of causing dangerous rhythms, while sotalol and dofetilide can prolong the QT interval on your EKG and amiodarone can affect the thyroid, liver and lungs with long-term use. Some medications like dofetilide require hospital monitoring when starting. Regular follow-up with bloodwork and EKGs helps your care team catch problems early.
- Do these medications cure AFib
-
No. Antiarrhythmic medications help maintain normal heart rhythm and reduce AFib symptoms, but they may not fully prevent all episodes. Many patients benefit most from a combined approach that may include medication plus cardioversion (electrical reset) or ablation, depending on their specific heart condition and AFib type.
- When should I consider switching from medication to ablation?
-
Consider ablation if medication isn’t controlling your symptoms, if side effects are limiting your quality of life, or if AFib returns despite medication. Ablation can also be considered as a first-line option in lieu of antiarrhythmic drugs. This is a shared-decision process between you and your electrophysiologist, who will discuss your AFib type, heart structure and preferences to help you choose the best path forward.